Literature DB >> 28573549

Periprosthetic Joint Infection Is the Main Cause of Failure for Modern Knee Arthroplasty: An Analysis of 11,134 Knees.

Chuan Kong Koh1, Irene Zeng2, Saiprassad Ravi3, Mark Zhu4, Kelly G Vince5, Simon W Young4.   

Abstract

BACKGROUND: Although large series from national joint registries may accurately reflect indications for revision TKAs, they may lack the granularity to detect the true incidence and relative importance of such indications, especially periprosthetic joint infections (PJI). QUESTIONS/PURPOSES: Using a combination of individual chart review supplemented with New Zealand Joint Registry data, we asked: (1) What is the cumulative incidence of revision TKA? (2) What are the common indications for revising a contemporary primary TKA? (3) Do revision TKA indications differ at various followup times after primary TKA?
METHODS: We identified 11,134 primary TKAs performed between 2000 and 2015 in three tertiary referral hospitals. The New Zealand Joint Registry and individual patient chart review were used to identify 357 patients undergoing subsequent revision surgery or any reoperation for PJI. All clinical records, radiographs, and laboratory results were reviewed to identify the primary revision reason. The cumulative incidence of each revision reason was calculated using a competing risk estimator.
RESULTS: The cumulative incidence for revision TKA at 15 years followup was 6.1% (95% CI, 5.1%-7.1%). The two most-common revision reasons at 15 years followup were PJI followed by aseptic loosening. The risk of revision or reoperation for PJI was 2.0% (95% CI, 1.7%-2.3%) and aseptic loosening was 1.2% (95% CI, 0.7%-1.6%). Approximately half of the revision TKAs secondary to PJI occurred within 2 years of the index TKA (95% CI, 0.8%-1.2%), whereas half of the revision TKAs secondary to aseptic loosening occurred 8 years after the index TKA (95% CI, 0.4%-0.7%).
CONCLUSIONS: In this large cohort of patients with comprehensive followup of revision procedures, PJI was the dominant reason for failure during the first 15 years after primary TKA. Aseptic loosening became more important with longer followup. Efforts to improve outcome after primary TKA should focus on these areas, particularly prevention of PJI. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2017        PMID: 28573549      PMCID: PMC5539036          DOI: 10.1007/s11999-017-5396-4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  24 in total

1.  Publication of surgeon level data from registers: who benefits?

Authors:  F S Haddad; A R J Manktelow; J A Skinner
Journal:  Bone Joint J       Date:  2016-01       Impact factor: 5.082

2.  Tibial component failure mechanisms in total knee arthroplasty.

Authors:  Michael E Berend; Merrill A Ritter; John B Meding; Philip M Faris; E Michael Keating; Ryan Redelman; Gregory W Faris; Kenneth E Davis
Journal:  Clin Orthop Relat Res       Date:  2004-11       Impact factor: 4.176

3.  Why are total knee arthroplasties being revised?

Authors:  David F Dalury; Donald L Pomeroy; Robert S Gorab; Mary Jo Adams
Journal:  J Arthroplasty       Date:  2013-07-23       Impact factor: 4.757

4.  Why are total knees failing today? Etiology of total knee revision in 2010 and 2011.

Authors:  William C Schroer; Keith R Berend; Adolph V Lombardi; C Lowry Barnes; Michael P Bolognesi; Michael E Berend; Merrill A Ritter; Ryan M Nunley
Journal:  J Arthroplasty       Date:  2013-08-15       Impact factor: 4.757

5.  New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society.

Authors:  Javad Parvizi; Benjamin Zmistowski; Elie F Berbari; Thomas W Bauer; Bryan D Springer; Craig J Della Valle; Kevin L Garvin; Michael A Mont; Montri D Wongworawat; Charalampos G Zalavras
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

Review 6.  Modes of failure of total knee arthroplasty: registries and realities.

Authors:  Marcelo B P Siqueira; Alison K Klika; Carlos A Higuera; Wael K Barsoum
Journal:  J Knee Surg       Date:  2014-11-24       Impact factor: 2.757

Review 7.  The problem total knee replacement: systematic, comprehensive and efficient evaluation.

Authors:  K G Vince
Journal:  Bone Joint J       Date:  2014-11       Impact factor: 5.082

8.  The Swedish knee arthroplasty register. A nation-wide study of 30,003 knees 1976-1992.

Authors:  K Knutson; S Lewold; O Robertsson; L Lidgren
Journal:  Acta Orthop Scand       Date:  1994-08

9.  Why are total knee arthroplasties failing today--has anything changed after 10 years?

Authors:  Peter F Sharkey; Paul M Lichstein; Chao Shen; Anthony T Tokarski; Javad Parvizi
Journal:  J Arthroplasty       Date:  2014-07-05       Impact factor: 4.757

10.  New Zealand Joint Registry data underestimates the rate of prosthetic joint infection.

Authors:  Mark Zhu; Saiprasad Ravi; Chris Frampton; Chris Luey; Simon Young
Journal:  Acta Orthop       Date:  2016-06-27       Impact factor: 3.717

View more
  50 in total

1.  Fifteen-year survival of the Cedior™ total knee prosthesis.

Authors:  Roger Erivan; Edouard Fadlallah; Guillaume Villatte; Aurélien Mulliez; Stéphane Descamps; Stéphane Boisgard
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-06

2.  One-stage exchange with antibacterial hydrogel coated implants provides similar results to two-stage revision, without the coating, for the treatment of peri-prosthetic infection.

Authors:  Nicola Capuano; Nicola Logoluso; Enrico Gallazzi; Lorenzo Drago; Carlo Luca Romanò
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-16       Impact factor: 4.342

3.  CORR Insights®: Weighing in on Body Mass Index and Infection After Total Joint Arthroplasty: Is There Evidence for a Body Mass Index Threshold?

Authors:  Bernd Fink
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

4.  Infection and periprosthetic fracture are the leading causes of failure after aseptic revision total knee arthroplasty.

Authors:  Juliette A Meyer; Mark Zhu; Alana Cavadino; Brendan Coleman; Jacob T Munro; Simon W Young
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-30       Impact factor: 3.067

Review 5.  [Revision surgery in acute periprosthetic knee joint infections].

Authors:  T Hawellek; F T Beil; J Hubert
Journal:  Oper Orthop Traumatol       Date:  2018-07-27       Impact factor: 1.154

6.  Functional outcome of two-stage reimplantation in patients with periprosthetic joint infection after primary total knee arthroplasty.

Authors:  Petr Mikhailovich Preobrazhensky; Svetlana Anatolievna Bozhkova; Alexander Viktorovich Kazemirsky; Rashid Murtazalievich Tikhilov; Taras Andreevich Kulaba; Nikolai Nikolaevich Kornilov
Journal:  Int Orthop       Date:  2019-01-16       Impact factor: 3.075

7.  Orthopedic surgery approach with uncemented metallic prosthesis in knee osteoarthritis increases the quality of life of young patients.

Authors:  Bogdan Uivaraseanu; Simona Bungau; Delia Mirela Tit; Tapan Behl; Teodor Andrei Maghiar; Octavian Maghiar; Carmen Pantis; Dana Carmen Zaha; Jenel M Patrascu
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

8.  Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030.

Authors:  Andrew M Schwartz; Kevin X Farley; George N Guild; Thomas L Bradbury
Journal:  J Arthroplasty       Date:  2020-02-19       Impact factor: 4.757

9.  Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty.

Authors:  Nicholas P Drain; Valerie C Gobao; Dominique M Bertolini; Clair Smith; Neel B Shah; Scott D Rothenberger; Malcolm E Dombrowski; Michael J O'Malley; Brian A Klatt; Brian R Hamlin; Kenneth L Urish
Journal:  J Arthroplasty       Date:  2020-03-04       Impact factor: 4.757

Review 10.  Current Options and Emerging Biomaterials for Periprosthetic Joint Infection.

Authors:  Ashley E Levack; Erika L Cyphert; Mathias P Bostrom; Christopher J Hernandez; Horst A von Recum; Alberto V Carli
Journal:  Curr Rheumatol Rep       Date:  2018-04-30       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.